tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market

Dermapharm Holding SE (DMP) Financial Statements

Compare
11 Followers

Dermapharm Holding SE Financial Overview

Dermapharm Holding SE's market cap is currently €2.06B. The company's EPS TTM is €1.682; its P/E ratio is 23.27; and it has a dividend yield of 2.25%. Dermapharm Holding SE is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 1.14B€ 1.02B€ 942.91M€ 793.83M€ 700.88M
Gross Profit€ 719.16M€ 660.83M€ 620.69M€ 463.48M€ 383.72M
Operating Income€ 182.89M€ 243.69M€ 298.47M€ 136.85M€ 119.51M
EBITDA€ 265.55M€ 329.81M€ 358.10M€ 186.57M€ 172.20M
Net Income€ 62.37M€ 134.24M€ 209.58M€ 85.83M€ 77.20M
Balance Sheet
Cash & Short-Term Investments€ 159.54M€ 161.36M€ 172.06M€ 121.66M€ 116.04M
Total Assets€ 2.16B€ 1.41B€ 1.41B€ 1.22B€ 1.04B
Total Debt€ 1.08B€ 516.45M€ 580.30M€ 606.80M€ 554.61M
Net Debt€ 921.66M€ 366.53M€ 419.98M€ 486.18M€ 439.63M
Total Liabilities€ 1.62B€ 880.34M€ 907.13M€ 899.81M€ 760.38M
Stockholders' Equity€ 539.21M€ 531.59M€ 497.32M€ 321.97M€ 278.65M
Cash Flow
Free Cash Flow€ 177.88M€ 249.52M€ 189.16M€ 90.30M€ 54.17M
Operating Cash Flow€ 219.42M€ 288.53M€ 250.37M€ 131.10M€ 100.61M
Investing Cash Flow€ -415.43M€ -99.01M€ -129.35M€ -105.91M€ -382.15M
Financing Cash Flow€ 204.54M€ -199.77M€ -80.98M€ -14.09M€ 183.96M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

Dermapharm Holding SE Debt to Assets

Dermapharm Holding SE Cash Flow

Dermapharm Holding SE Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis